More on TRAW

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+96.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (2/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Traws Pharma (NQ:TRAW)
Delayed: 1.60 --0 (-0%)
Prev. Close $1.60  
Open$1.61 
52 Wk High$ 
52 Wk Low$ 
Day High$1.66 
Day Low$1.53 
P/E N/A  
EPS$ 
Volume63,356 

Friends, Peers and Foes (?): ANVS, IKNA IOVA (more...)

Feb 19, 2026 08:43 AM Form 8-K Traws Pharma, Inc. For: Feb 19
Feb 17, 2026 05:12 PM Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Ikarian Capital, LLC
Feb 17, 2026 12:36 PM Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Squadron Capital Management LLC
Feb 12, 2026 09:11 AM Form SCHEDULE 13G Traws Pharma, Inc. Filed by: Adage Capital Management, L.P.
Feb 11, 2026 09:44 AM Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Ayrton Capital LLC
Jan 30, 2026 06:42 AM Ladenburg Thalmann Starts Traws Pharma Inc. (TRAW) at Buy
Jan 26, 2026 08:32 AM Traws Pharma completes enrollment in COVID-19 drug study
Jan 26, 2026 08:31 AM Form 8-K Traws Pharma, Inc. For: Jan 26
Jan 26, 2026 08:30 AM Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic T
Jan 16, 2026 04:48 PM Form SCHEDULE 13G Traws Pharma, Inc. Filed by: Chernett Jorey
View All Articles

Entities mentioned with TRAW

View All Entities